Home » News » AIM News » Sativa Group appoint King’s College London Professor to the Board
Sativa Group plc

Sativa Group appoint King’s College London Professor to the Board

Sativa Group (NEX:SATI), the UK’s leading quoted CBD wellness and medicinal cannabis Group, has appointed Clive Page, Professor of Pharmacology at King’s College London, to its Medical Advisory Board.  Professor Page’s main research interests are in the pharmacology of inflammation and respiratory disease, and he has published over 300 scientific papers and book chapters.  

He was awarded the Sandoz Prize from the British Pharmacological Society in 1988, The Tanabe Young Investigators Prize from the American College of Clinical Pharmacology in 1996 and the Society of Biology President’s Medal in 2012 for “Outstanding Contributions to the Life Sciences”.  He is a Fellow of the Royal Society of Biology and an Honorary Fellow of the British Pharmacological Society.  Professor Page was awarded an OBE for “Services to Pharmacology” in 2017.

Dr Nick Horniman, Director of Regulatory Affairs at Sativa, said:  “Professor Page is an eminent research scientist and will add to Sativa’s experience, interest and understanding in cannabis based medical products.”